Authors
1 Department of Internal Medicine, School of Medicine, Yasuj University of Medical Sciences, Yasuj
2 Gastrointestinal and Hepatobiliary Diseases Research Center, Poursina Hakim Research Institute for Health Care Development, Isfahan,
3 Molecular Clinical Microbiology Subdivision, Clinical Pathology Division, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract
CONTEXT AND AIMS: We aimed to evaluate the effectiveness of hydroalcoholic extract of Quercus
brantii’s nut on clinical, endoscopic, and pathological findings of patients with dyspepsia.
PATIENTS AND METHODS: In this randomized, double-blind clinical trial, patients with symptomatic
dyspepsia who had an endoscopic evaluation for dyspepsia were included and randomized into two
groups. One Group (A) received drug extract with a dose of 100 mg twice a day for 10 days. Group B,
as a control group, received placebo. Immediately and 2 months after intervention, the patients were
followed up, and the characteristics of their dyspepsia (severity and frequency), endoscopic and
pathologic fi ndings were reevaluated and compared.
RESULTS: In this trial, 13 and ten patients participated in the study in Groups A and B, respectively.
Two months after intervention, ten (76.9%) and six (60%) participants referred for follow-up
and endoscopic evaluation. There were no signifi cant changes in clinical presentations after
intervention (P > 0.05). Two months after intervention, clinical presentations including severity and
frequency of epigastric pain had signifi cant decrease in Group A and endoscopic evaluation indicated
signifi cant improvement in Group A (P < 0.05). Pathologic fi ndings were similar and not signifi cantly
different in two studied groups after intervention (P > 0.05).
CONCLUSIONS: The fi ndings of this trial indicated that hydroalcoholic extract of Q. brantii’s nut
could have delayed signifi cant proper effect on clinical and endoscopic presentations of patients
with dyspepsia. We recommend that this study should be considered as pilot one in this fi eld. The
results could be used as baseline data for more interventional studies. More surveys are needed to
investigate the mechanism of extract action at molecular basis.
Keywords
and risk factors of functional dyspepsia: A nationwide multicenter
prospective study in Korea. J Clin Gastroenterol 2014;48:e12-8.
2. Geeraerts B, Tack J. Functional dyspepsia: Past, present, and
future. J Gastroenterol 2008;43:251-5.
3. Shaib Y, El-Serag HB. The prevalence and risk factors of functional
dyspepsia in a multiethnic population in the United States. Am
J Gastroenterol 2004;99:2210-6.
4. Kumar A, Pate J, Sawant P. Epidemiology of functional dyspepsia.
J Assoc Physicians India 2012;60:9-12.
5. Masoumi SJ, Mehrabani D, Moradi F, Zare N, Saberi-Firouzi M,
Mazloom Z. The prevalence of dyspepsia symptoms and its
correlation with the quality of life among Qashqai Turkish
migrating nomads in Fars Province, Southern Iran. Pak J Med
Sci 2015;31:325-30.
6. El-Serag HB, Talley NJ. Health-related quality of life in functional
dyspepsia. Aliment Pharmacol Ther 2003;18:387-93.
7. Thompson Coon J, Ernst E. Systematic review: Herbal medicinal
products for non-ulcer dyspepsia. Aliment Pharmacol Ther
2002;16:1689-99.
8. Brun R, Kuo B. Functional dyspepsia. Therap Adv Gastroenterol
2010;3:145-64.
9. World Health Organization. WHO Monographs on Selected
Medicinal Plants. Geneva: WHO Publications; 2007.
10. Babaeian M, Naseri M, Kamalinejad M, Ghaffari F, Emadi F,
Feizi A, et al. Herbal remedies for functional dyspepsia and
traditional Iranian medicine perspective. Iran Red Crescent Med
J 2015;17:e20741.
11. Sork VL, Fitz-Gibbon ST, Puiu D, et al. First Draft Assembly
and Annotation of the Genome of a California Endemic Oak
Quercus lobata Née (Fagaceae). G3 (Bethesda). 2016 Sep 12. pii:
g3.116.030411.
12. Alkofahi A, Atta AH. Pharmacological screening of the
anti-ulcerogenic effects of some Jordanian medicinal plants in
rats. J Ethnopharmacol 1999;67:341-5.
13. Mirzaei A, Mirzaei M, Khosravani SA, Salehpour Z. Radical
scavenging potential of Iranian Quercus brantii and Juglans regia.
Life Sci J 2013;10:1246-50.
14. Hikino H. Recent research on oriental medicinal plants. In:
Wagner H, Hikino H, Farnsworth NR, editors. Economic and
Medicinal Plant Research. London: Academic Press; 1985. p. 53-85.
15. Ahvazi M, Khalighi-Sigaroodi F, Charkhchiyan MM, Mojab F,
Mozaffarian VA, Zakeri H. Introduction of medicinal plants
species with the most traditional usage in alamut region. Iran J
Pharm Res 2012;11:185-94.
16. Kermani N. Explanation of causes and signs (Description of
causes and signs). Tehran Research Institute for Islamic and
Complementary Medicine Publication; 2008.
17. Dolatkhahi M, Dolatkhahi A, Nejad JB. Ethnobotanical study of
medicinal plants used in Arjan – Parishan protected area in Fars
Province of Iran. Avicenna J Phytomed 2014;4:402-12.18. Sadeghian I, Hassanshahian M, Sadeghian S, Jamali S.
Antimicrobial effects of Quercus brantii fruits on bacterial
pathogens. Jundishapur J Microbiol 2012;5:465-9.
19. Azizi S, Ghasemi Pirbalouti A, Amirmohammadi M. Effect
of hydro-alcoholic extract of Persian oak (Quercus brantii) in
experimentally gastric ulcer. Iran J Pharm Res 2014;13:967-74.
20. Moradi MT, Karimi A, Alidadi S. In vitro antiproliferative and
apoptosis-inducing activities of crude ethyl alcohol extract of
Quercus brantii L. acorn and subsequent fractions. Chin J Nat Med
2016;14:196-202.
)